Haleon (HLN) Operating Income Growth (1y) (2022 - 2023)

Haleon (HLN) Operating Income Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Haleon 89.55 Bn 87.69 Bn - -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn 25.63%
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn -1.30%
4 Takeda Pharmaceutical 27.52 Bn 23.45 Bn 4.39 Bn -319.32%
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn -14.89%
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn 97.23%
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn 719.49%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 21.25%
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 350.00%

Historic Data

Download Data
DateValue
Dec 31, 2023 24.26%
Dec 31, 2022 2.75%